Hidetaka Niizuma

Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma

Hidetaka Niizuma, Yohko Nakamura, Toshinori Ozaki et al. · Oncogene · 2006 · 79 citations

Life Sciences, Cell Biology, Oncology +13

Hematopoietic Stem Cell Transplantation for XIAP Deficiency in Japan

Shintaro Ono, Tsubasa Okano, Akihiro Hoshino et al. · Journal of Clinical Immunology · 2016 · 67 citations · Full text

Medicine, Genetics, Hematology +8

Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line

Yohko Nakamura, Toshinori Ozaki, Hidetaka Niizuma et al. · Biochemical and Biophysical Research Communications · 2007 · 45 citations

Life Sciences, Genetics, Molecular Genetics +10

PTHrP‐independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19‐negative precursor B acute lymphoblastic leukemia

Hidetaka Niizuma, Kunihiro Fujii, Atsushi Satō et al. · Pediatric Blood & Cancer · 2006 · 39 citations

Medicine, Endocrinology, Immunology +16

Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation

Kunihiko Moriya, Tasuku Suzuki, Nao Uchida et al. · International Journal of Hematology · 2020 · 34 citations

Life Sciences, Immunology, Pharmacology +11